Modern institutions run on software that cannot fail. The cost of downtime — measured in dollars, in regulatory exposure, in the trust of the institutions that depend on them — is now larger than the cost of the software itself. Yet the discipline of continuity for these systems remains improvised, addressed company by company, with no standard worth its name.

Vault Genome is built to be that standard. The company provides a continuity platform for production software systems: a coherent representation of the state of a system, a recovery pathway that survives the kind of failures that take infrastructure down, and an access discipline that withstands counsel-grade scrutiny.

The institutional problem we address

Continuity, in its proper form, is not a backup. It is a guarantee that a system can be brought back into a state in which the institution operating it is able to defend the decisions taken on its behalf. That is a different problem from data preservation, and the literature on it is thin.

Vault Genome treats continuity as a primitive: a structured representation of system state, an audit-grade recovery pathway, and a permissioning model that survives the personnel changes, jurisdiction shifts, and adversarial events that classical disaster-recovery does not contemplate.

What the company builds

Market and posture

The customers are the institutions for which downtime is not a productivity question but a fiduciary one — regulated industry, mission-critical software vendors, sovereign and quasi-sovereign operators. The firm believes there is a category to be defined here, and that the category will be defined by whoever first treats continuity as a product rather than a service.